Intralymphatic immunotherapy with tyrosine-adsorbed allergens: a double-blind, placebo-controlled trial.

Park HJ, Kim SH, Shin YS, Park CH, Cho ES, Choi SJ, Park SH, Jung JH, Kang IG, Lee MS, Kim DW, Lee SM, Yang MS, Lee SP

Open source

DOI
10.1186/s12931-021-01766-0
Published
2021 Jun 4
Container
Respiratory research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12931-021-01766-0,
  title = {Intralymphatic immunotherapy with tyrosine-adsorbed allergens: a double-blind, placebo-controlled trial.},
  author = {Park HJ and Kim SH and Shin YS and Park CH and Cho ES and Choi SJ and Park SH and Jung JH and Kang IG and Lee MS and Kim DW and Lee SM and Yang MS and Lee SP},
  year = {2021},
  journal = {Respiratory research},
  doi = {10.1186/s12931-021-01766-0},
  url = {https://doi.org/10.1186/s12931-021-01766-0}
}

RIS

TY  - JOUR
TI  - Intralymphatic immunotherapy with tyrosine-adsorbed allergens: a double-blind, placebo-controlled trial.
AU  - Park HJ
AU  - Kim SH
AU  - Shin YS
AU  - Park CH
AU  - Cho ES
AU  - Choi SJ
AU  - Park SH
AU  - Jung JH
AU  - Kang IG
AU  - Lee MS
AU  - Kim DW
AU  - Lee SM
AU  - Yang MS
AU  - Lee SP
PY  - 2021
JO  - Respiratory research
DO  - 10.1186/s12931-021-01766-0
UR  - https://doi.org/10.1186/s12931-021-01766-0
ER  - 

APA

HJ, P., SH, K., YS, S., CH, P., ES, C., SJ, C., SH, P., JH, J., IG, K., MS, L., DW, K., SM, L., MS, Y., & SP, L. (2021). Intralymphatic immunotherapy with tyrosine-adsorbed allergens: a double-blind, placebo-controlled trial.. Respiratory research. https://doi.org/10.1186/s12931-021-01766-0

Source records